National Institutes of Health
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing November 13, 2026.
Nov 13, 2026
(105d left)